Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Footnotes
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Retraction Open Access | 10.1172/JCI211875

Retraction of TREM2 aggravates sepsis by inhibiting fatty acid oxidation via the SHP1/BTK axis

Siqi Ming, Xingyu Li, Qiang Xiao, Siying Qu, Qiaohua Wang, Qiongyan Fang, Pingping Liang, Yating Xu, Jingwen Yang, Yongqiang Yang, Xi Huang, and Yongjian Wu

Find articles by Ming, S. in: PubMed | Google Scholar

Find articles by Li, X. in: PubMed | Google Scholar

Find articles by Xiao, Q. in: PubMed | Google Scholar

Find articles by Qu, S. in: PubMed | Google Scholar

Find articles by Wang, Q. in: PubMed | Google Scholar

Find articles by Fang, Q. in: PubMed | Google Scholar

Find articles by Liang, P. in: PubMed | Google Scholar

Find articles by Xu, Y. in: PubMed | Google Scholar

Find articles by Yang, J. in: PubMed | Google Scholar

Find articles by Yang, Y. in: PubMed | Google Scholar

Find articles by Huang, X. in: PubMed | Google Scholar

Find articles by Wu, Y. in: PubMed | Google Scholar |

Published September 1, 2026 - More info

Published in Volume 136, Issue 17 on September 1, 2026
J Clin Invest. 2026;136(17):e211875. https://doi.org/10.1172/JCI211875.
© 2026 Ming et al. This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Published September 1, 2026 - Version history
View PDF

Related article:

TREM2 aggravates sepsis by inhibiting fatty acid oxidation via the SHP1/BTK axis
Siqi Ming, Xingyu Li, Qiang Xiao, Siying Qu, Qiaohua Wang, Qiongyan Fang, Pingping Liang, Yating Xu, Jingwen Yang, Yongqiang Yang, Xi Huang, Yongjian Wu
Siqi Ming, Xingyu Li, Qiang Xiao, Siying Qu, Qiaohua Wang, Qiongyan Fang, Pingping Liang, Yating Xu, Jingwen Yang, Yongqiang Yang, Xi Huang, Yongjian Wu
TREM2 aggravates sepsis by inhibiting macrophage fatty acid oxidation via SHP1-BTK axis
Research Article Infectious disease

TREM2 aggravates sepsis by inhibiting fatty acid oxidation via the SHP1/BTK axis

  • Text
  • PDF
Abstract

Impaired fatty acid oxidation (FAO) and the therapeutic benefits of FAO restoration have been revealed in sepsis. However, the regulatory factors contributing to FAO dysfunction during sepsis remain inadequately clarified. In this study, we identified a subset of lipid-associated macrophages characterized by high expression of trigger receptor expressed on myeloid cells 2 (TREM2) and demonstrated that TREM2 acted as a suppressor of FAO to increase the susceptibility to sepsis. TREM2 expression was markedly upregulated in sepsis patients and correlated with the severity of sepsis. Knockout of TREM2 in macrophages improved the survival rate and reduced inflammation and organ injuries of sepsis mice. Notably, TREM2-deficient mice exhibited decreased triglyceride accumulation and an enhanced FAO rate. Further observations showed that the blockade of FAO substantially abolished the alleviated symptoms observed in TREM2-knockout mice. Mechanically, we demonstrated that TREM2 interacted with the phosphatase SHP1 to inhibit bruton tyrosine kinase–mediated (BTK-mediated) FAO in sepsis. Our findings expand the understanding of FAO dysfunction in sepsis and reveal TREM2 as a critical regulator of FAO that may provide a promising target for the clinical treatment of sepsis.

Authors

Siqi Ming, Xingyu Li, Qiang Xiao, Siying Qu, Qiaohua Wang, Qiongyan Fang, Pingping Liang, Yating Xu, Jingwen Yang, Yongqiang Yang, Xi Huang, Yongjian Wu

×

Original citation: J Clin Invest. 2025;135(1):e159400. https://doi.org/10.1172/JCI159400

Citation for this retraction: J Clin Invest. 2026;136(17):e211875. https://doi.org/10.1172/JCI211875

At the request of the corresponding author, the JCI is retracting this article. The authors recently became aware that in Figure 5F and 5G, the fatty acid oxidation (FAO) rates reported were incorrect due to a failure to normalize the data to the protein concentration in the lysates. After properly normalizing the FAO data, the authors found that treatment with ibrutinib or LFM-A13 did not rescue the FAO rate in TREM2-deficient macrophages. Given the importance of these figures in supporting the key findings of the paper, the authors felt that retraction was the most responsible course of action.

The authors apologize for the errors.

Footnotes

See the related article at TREM2 aggravates sepsis by inhibiting fatty acid oxidation via the SHP1/BTK axis.

Version history
  • Version 1 (September 1, 2026): Electronic publication

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Footnotes
  • Version history
Advertisement
Advertisement

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts